DOTA-CXCR4-L
DOTA-CXCR4-L is a peptide-based research compound targeting the CXCR4 receptor. It is applied in oncology research, including studies on glioblastoma and triple-negative breast cancer, for in vitro and in vivo investigation of CXCR4-mediated signaling pathways.
Product Specifications
Field of Research
Cell Biology, Immunology & Inflammation, Pharmacology & Drug Discovery
Molecular Weight
1223.34
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog